Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zhejiang Kanova Biopharmaceutical Co., Ltd

Clinical trials sponsored by Zhejiang Kanova Biopharmaceutical Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new antibody tame the Body's allergic alarm system? Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 2 Completed 1

New drug XKH004 shows promise in phase 3 trial for back pain from ankylosing spondylitis

Disease control Completed

This Phase 3 trial tested a new drug called XKH004 in 323 adults with moderate-to-severe active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. The drug works by blocking two inflammatory proteins, IL-17A and IL-17F. Participants received either X…

Phase 3 • Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC